Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VRVg rabies vaccine in simulated post-exposure prophylaxis
NCT04478084Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine serum-free vero cell in rabies, sponsored by Sanofi. Started Aug 2020; status: completed.
02
Drugs
rabies vaccine serum-free vero cell
03
Conditions
rabies
Beyond the preview
Go deeper on NCT04478084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478084.